These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15726655)

  • 1. The human liver clears both asymmetric and symmetric dimethylarginine.
    Siroen MP; van der Sijp JR; Teerlink T; van Schaik C; Nijveldt RJ; van Leeuwen PA
    Hepatology; 2005 Mar; 41(3):559-65. PubMed ID: 15726655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia.
    Nijveldt RJ; Siroen MP; Teerlink T; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
    Liver Int; 2004 Oct; 24(5):510-8. PubMed ID: 15482350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).
    Nijveldt RJ; Teerlink T; Siroen MP; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
    Clin Nutr; 2003 Feb; 22(1):17-22. PubMed ID: 12553945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia.
    Nijveldt RJ; Teerlink T; van Guldener C; Prins HA; van Lambalgen AA; Stehouwer CD; Rauwerda JA; van Leeuwen PA
    Nephrol Dial Transplant; 2003 Dec; 18(12):2542-50. PubMed ID: 14605276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
    Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
    J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects.
    Paroni R; Fermo I; Fiorina P; Cighetti G
    Amino Acids; 2005 Jun; 28(4):389-94. PubMed ID: 15827687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).
    Tain YL; Hsu CN
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28272322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans.
    Nijveldt RJ; Van Leeuwen PA; Van Guldener C; Stehouwer CD; Rauwerda JA; Teerlink T
    Nephrol Dial Transplant; 2002 Nov; 17(11):1999-2002. PubMed ID: 12401860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G; Fermo I; Aman CS; Ferraroni M; Secchi A; Fiorina P; Paroni R
    Free Radic Biol Med; 2009 Aug; 47(3):307-11. PubMed ID: 19446631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of symmetric dimethylarginine in hepatorenal syndrome.
    Lluch P; Mauricio MD; Vila JM; Segarra G; Medina P; Del Olmo JA; Rodrigo JM; Serra MA
    Exp Biol Med (Maywood); 2006 Jan; 231(1):70-5. PubMed ID: 16380646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of asymmetric and symmetric dimethylarginines in renal disease.
    Schwedhelm E; Böger RH
    Nat Rev Nephrol; 2011 May; 7(5):275-85. PubMed ID: 21445101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human taurine metabolism: fluxes and fractional extraction rates of the gut, liver, and kidneys.
    van Stijn MF; Vermeulen MA; Siroen MP; Wong LN; van den Tol MP; Ligthart-Melis GC; Houdijk AP; van Leeuwen PA
    Metabolism; 2012 Jul; 61(7):1036-40. PubMed ID: 22304837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F; Kautzky-Willer A; Winzer C; Krzyzanowska K; Prikoszovich T; Demehri S; Wagner O; Wolzt M
    J Intern Med; 2007 Apr; 261(4):392-8. PubMed ID: 17391114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
    Oliva-Damaso E; Oliva-Damaso N; Rodriguez-Esparragon F; Payan J; Baamonde-Laborda E; Gonzalez-Cabrera F; Santana-Estupiñan R; Rodriguez-Perez JC
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA.
    Bulau P; Zakrzewicz D; Kitowska K; Leiper J; Gunther A; Grimminger F; Eickelberg O
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L18-24. PubMed ID: 16891395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.
    Siroen MP; Wiest R; Richir MC; Teerlink T; Rauwerda JA; Drescher FT; Zorger N; van Leeuwen PA
    World J Gastroenterol; 2008 Dec; 14(47):7214-9. PubMed ID: 19084936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.